Abstract:BACKGROUNDNo-reflow phenomenon after reperfusion treatment of acute myocardial infarction (AMI) is becoming more recognized today. The effective treatment for no-reflow has not been reported.OBJECTIVETo observe the effects of traditional Chinese medicine (TCM) therapy for replenishing qi, nourishing yin, and promoting blood circulation on AMI patients undergoing percutaneous coronary intervention (PCI).DESIGN, SETTING, PARTICIPANTS AND INTERVENTIONSThis study was conducted from January 2005 to March 2006 using a double-blinded, randomized method. Thirty-five AMI patients (Killip I-II) were first diagnosed as ST segment elevation AMI and obtained primary PCI. They were recruited from People's Hospital, Peking University. All patients' symptoms accorded with qi-yin deficiency syndrome and blood stasis syndrome. They were randomly and double blindly divided into control group (18 cases) and treatment group (17 cases). The patients in the control group received Western medicine treatment, and the patients in the treatment group were treated with Western medicine plus American ginseng and Salviae miltiorrhizae preparations. They were all treated for 3 months.MAIN OUTCOME MEASURESBefore and after 3-month treatment, the TCM symptoms were observed and scored. At the state of baseline and dobutamine stress, left ventricular ejection fraction (LVEF), wall motion score (WMS), WMS index and normal cardiac muscle percentage (NCMP), and the myocardial contrast echocardiography index k, which reflects myocardium microcirculation perfusion, were detected.RESULTSAfter 3-month treatment, the TCM symptoms in the treatment group were improved as compared with the control group (X(2)=4.118, P=0.042). At the state of dobutamine stress, LVEF in the treatment group after treatment was higher than those in the control group (t=2.130, P=0.041) and before treatment (t=2.345, P=0.032). Although the number of the segments with increased k value was more than that in the control group, there was no significant difference.CONCLUSIONTCM therapy for replenishing qi, nourishing yin and promoting blood circulation can improve the clinical symptoms and quality of life of the AMI patients undergoing PCI, and is beneficial to myocardium microcirculation. Thus, it may be an alternative cardioprotective treatment strategy for successful myocardial microcirculation in AMI patients after reperfusion.

Cardiotonic Pills®Post‐treatment Ameliorates Ischemia‐Reperfusion Induced Myocardial Microcirculatory Disturbances and Myocardial Lesions

Cardiotonic pills, a compound Chinese medicine, protects ischemia-reperfusion-induced microcirculatory disturbance and myocardial damage in rats

Treatment With Cardiotonic Pills (R) After Ischemia-Reperfusion Ameliorates Myocardial Fibrosis In Rats

Pre-treatment with Cardiotonic Pills Attenuates Ischemia-reperfusion-induced Myocardial Blood Flow and Myocardial Injury in Rats

Cardioprotection of Ischemic Postconditioning Against Ischemia/reperfusion Injury in Isolated Rat Hearts

[Auricularia Auricular Polysaccharide Protects Myocardium Against Ischemia/reperfusion Injury].

The Attenuation Effects of Single Dose Cardiotonic Pills on Myocardial Blood Flow and Myocardial Damage Induced by Myocardial Ischemia Reperfusion

Inhibition of NADPH Oxidase Mediates Protective Effect of Cardiotonic Pills against Rat Heart Ischemia/Reperfusion Injury.

Cardioprotection by Polysaccharide Sulfate Against Ischemia/reperfusion Injury in Isolated Rat Hearts.

Low Dose Cyclophosphamide Rescues Myocardial Function from Ischemia-Reperfusion in Rats

Cardiotonic Pills® protects from myocardial fibrosis caused by in stent restenosis in miniature pigs

Attenuating Effects of Cardiotonic Pill@ and Its Major Ingredients,Salviae Miltiorrhiza,and Panax Notoginseng on the Microcirculatory Disturbance Induced by Ischemia and Reperfusion in Rat Mesentery.

Herbal Cardiotonic Pills Prevent Gut Ischemia/reperfusion-Induced Hepatic Microvascular Dysfunction in Rats Fed Ethanol Chronically

Postconditioning with a CpG containing oligodeoxynucleotide ameliorates myocardial infarction in a murine closed-chest model.

QiShenYiQi Pills® Attenuates the Myocardial Injury and Microvascular Hyperpermeability Induced by Ischemia‐reperfusion in Rat, Via Regulation of Myocardial Energy

Cardiac patch treatment alleviates ischemic cardiomyopathy correlated with reverting Piezo1/2 expression by unloading left ventricular myocardium

The Synergistic Cardioprotective Effect of Ischemic Postconditioning and Preconditioning on Severe Ischemia/reperfusion Injury in Isolated Rat Heart

Effects and mechanisms of QiShenYiQi pills and major ingredients on myocardial microcirculatory disturbance, cardiac injury and fibrosis induced by ischemia-reperfusion

QiShenYiQi Pills® Prevents Cardiac Ischemia–reperfusion Injury Via Energy Modulation

QiShenYiQi Pills® ameliorates ischemia/reperfusion-induced myocardial fibrosis involving RP S19-mediated TGFβ1/Smads signaling pathway

[Therapy for Replenishing Qi, Nourishing Yin and Promoting Blood Circulation in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: a Randomized Controlled Trial].